[Tremor following the administration of a new beta receptor stimulator].
D000318:Adrenergic beta-Agonists / Q000009:adverse effects*; D000605:Amino Alcohols / Q000009:adverse effects*; D002082:Butylamines / Q000009:adverse effects; D006801:Humans; D012118:Resorcinols / Q000009:adverse effects; D014202:Tremor / Q000139:chemically induced*
D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D002082:Butylamines; D012118:Resorcinols
Tremor nach Gabe eines neuen Betarezeptorenstimulators.